This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Thrombectomy System Market

Market Insights on Thrombectomy System covering sales outlook, demand forecast & up-to-date key trends

Thrombectomy System Market by Type (Hydrodynamic, Ultrasound, Aspiration, and Mechanical Thrombectomy), Application, End User & Region - Forecast 2022-2032

Thrombectomy System Market Overview

The thrombectomy system market is anticipated to register a CAGR of 7.0% during the forecast period, with an estimated valuation of US$ 1.45 Bn by 2022.

Attributes

Details

Estimated Base Year Value (2022)

US$ 1.45 Bn

Projected Growth Rate (2022-2032)

7.0%

Sales of thrombectomy systems are expected to rise as increasing incidences of cardiovascular disorders in key markets, procedural benefits of mechanical thrombectomy in cardiac procedures, increased prevalence of thrombotic diseases among the elderly, and surgeons' rising preference for image-guided and minimally invasive cardiac surgeries.

In addition to this, demand for thrombectomy systems is rising on account of the growing target patient population, ongoing technical improvements, attractive medical reimbursements, increased demand for minimally invasive thrombectomy treatments, and rising healthcare expenditures.

Increasing incidences of cardiovascular illnesses have been linked to an increase in the geriatric population, which is also projected to contribute to the growth of the thrombectomy system market share.

The report sheds light on the factors improving the sales of thrombectomy system and, in turn, the opportunities for the market players. However, the thrombectomy system market also faces some challenges, which might limit the thrombectomy system market share from reaching its potential.

Some of the key thrombectomy system market trends promoting the demand for thrombectomy systems include a target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and rising healthcare expenditure across emerging markets. 

However, the majority of thrombectomy device manufacturers face a number of challenges in the global market, including a stringent regulatory environment, limited patient awareness resulting in delayed treatment for peripheral vascular diseases, and a scarcity of skilled and well-trained surgeons to perform thrombectomy procedures.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Drivers to the Thrombectomy System Market Share?

Presently, sales of thrombectomy systems are driven by technological advancement, an aging population, and increasing demand for minimally invasive surgery.

Demand for thrombectomy system is driven by the rise in the elderly population, technological advancement in the healthcare industry, increasing prevalence of cardiovascular diseases such as AAAs and PADs, patient lifestyle changes, and unhealthy habits. 

However, lack of skilled professionals and the lack of awareness about peripheral vascular disease among patients are major barriers to the sales of thrombectomy system.

Thrombectomy systems are used in several procedures which require clot removal to achieve efficacious treatment and to save patients' lives. Due to its versatility, the thrombectomy system can be utilized in several different applications like acute myocardial infarction (AMI), peripheral arterial disease (PAD), deep vein thrombosis (DVT), pulmonary embolism (PE), and neurovascular procedures, thereby positively impacting the sales of thrombectomy system.

With rapid technological advancement growing average age, the demand for thrombectomy systems is expected to have a healthy growth rate in the forecast period.

Which is the Leading Region in the Thrombectomy System Market?

Depending on geographic region, the global thrombectomy system market is segmented into seven key regions--North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America holds the largest share of demand for thrombectomy systems due to a high aging population and wide technological advancement.

During the forecast period, Asia-Pacific is expected to have the greatest CAGR for the sales of thrombectomy system.

The expansion of demand for thrombectomy system in North America is being fuelled by factors such as surgeons' increased acceptance of technologically sophisticated thrombectomy products, a growing number of clinical trials, and medical reimbursements available in the United States for thrombectomy treatments.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is the Competitive Landscape in the Thrombectomy System Market?

Some of the key participating players in the rising demand for thrombectomy systems are Bayer HealthCare LLC, Boston Scientific Corp., Covidien Plc., Minnetronix Inc., Argon Medical Devices Inc., NexGen Medical Systems Inc., and others.

To expand their product portfolio, the main competitors in the thrombectomy system market are focused on acquisitions and mergers. The players' strategy for remaining prominent and increasing the sales of thrombectomy systems is to launch new products for varied diameters of blood arteries, location of the thrombus, and size of the blood clot. 

The report consists of key players contributing to the thrombectomy system market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions.

This exclusive report analyzes the competitive landscape and thrombectomy system market share acquired by players to strengthen their market position.

Scope Of Report

Report Attribute

Details

Growth rate

CAGR of 7% from 2022 to 2032

Base year for estimation

2021

Historical data

2015 - 2020

Forecast period

2022 - 2032

Quantitative units

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,

Segments covered

Type, application, end user, region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

NexGen Medical Systems Inc., Bayer HealthCare LLC, Minnetronix Inc., Covidien Plc., Argon Medical Devices Inc., Boston Scientific Corp., and others.

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Frequently Asked Questions

The thrombectomy system market is forecasted to register a CAGR of 7% during the forecast period.

Key players holding substantial thrombectomy system market share include NexGen Medical Systems Inc., Bayer HealthCare LLC, Minnetronix Inc., Covidien Plc., Argon Medical Devices Inc., Boston Scientific Corp., and others.

Demand for the thrombectomy system is likely to rise on the back of an increase in the growing target population.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Thrombectomy System Market